In addition to the financing, Zenflow announced it has entered into an exclusive U.S. distribution agreement with Cook ...
New non-human primate data show Coave's ligand-conjugated suprachoroidal vector, coAAV-SCS, achieved up to 120-fold higher ...
Texas Ibogaine Research Corporation (“TIRC”), the wholly-owned Texas subsidiary of Psyence BioMed, enters manufacturing ...
New ISSCA curriculum covers multiple adjunctive technologies used in longevity-focused practices and is intended to ...
Inducement Plan. Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious ...
Composition of matter provides U.S. protection through Sept. 6, 2044, as forazapadin advances in Phase 2 development. TORONTO ...
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it will report third-quarter 2026 financial results ...
A new patent application covers Polyrizon’s proprietary mucoadhesive platform and its potential applications in nasal drug ...
Reflects the depth of expertise and innovation Aji Bio-Pharma brings to customers navigating increasingly demanding ...
The Agency reiterated its commitment to addressing the unmet need for treatment of congenital and tumor-related ...
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the formation of a Scientific Advisory Board (SAB) comprising ...
ATH434 50 mg significantly slowed functional decline in MSA by approximately 52% versus placebo on the 11-item UMSARS at Week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results